| Dr John D Oswalt, MD | |
|
1010 W 40th St, Austin, TX 78756-4010 | |
| (512) 459-8753 | |
| (512) 483-6807 |
| Full Name | Dr John D Oswalt |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 1010 W 40th St, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174547509 | NPI | - | NPPES |
| 117731301 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | D8375 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John D Oswalt, MD 1010 W 40th St, Austin, TX 78756-4010 Ph: (512) 459-8753 | Dr John D Oswalt, MD 1010 W 40th St, Austin, TX 78756-4010 Ph: (512) 459-8753 |
News Archive
A new study, released as a preprint on the medRxiv* server, discusses the typical symptoms and signs of this syndrome, with the intention of improving the specificity of detection and reporting.
This article out of Johns Hopkins reviewed the risk of renal cell carcinoma occurring as a secondary malignancy after chemotherapy in childhood.
For the second time this year, all three Rush hospitals -; Rush University Medical Center, Rush Oak Park Hospital and Rush-Copley Medical Center -; have received an 'A' grade, the highest possible, from the Leapfrog Group, a nonprofit patient safety watchdog organization.
Merck and Codexis, Inc. today announced that they have jointly been awarded the annual Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency for the development of a novel biocatalytic method for the synthesis of sitagliptin. In addition, a paper co-authored by Merck and Codexis scientists and published online June 17 in the peer-reviewed journal Science, details how an enzyme was systematically customized using Codexis technology to perform the key chemical step in the sitagliptin synthesis process.
Genzyme, a Sanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).
› Verified 7 days ago
Sara E Mendoza Crespo, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 4900 Mueller Blvd Ste 3s.003, Austin, TX 78723 Phone: 855-324-0091 | |
Dr. William F Kessler, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1010 W 40th St, Austin, TX 78756 Phone: 512-459-8753 Fax: 512-483-6807 | |
Dr. Emery W Dilling, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1010 W 40th St, Austin, TX 78756 Phone: 512-459-8753 Fax: 512-483-6807 | |
Carlos Miguel Mery, M.D., M.P.H. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 4900 Mueller Blvd, Austin, TX 78723 Phone: 855-324-0091 | |
Dr. Brendan P Dewan, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1010 W 40th St, Austin, TX 78756 Phone: 512-459-8753 Fax: 512-483-6807 | |
Stephen Dewan, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1010 W 40th St, Austin, TX 78756 Phone: 512-459-8753 Fax: 512-483-6828 |